Home » News » Nephrology » Secondary Hyperparathyroidism
Secondary Hyperparathyroidism
SECONDARY HYPERPARATHYROIDISM
Further, baseline vitamin D-related biomarkers lower for individuals with higher BMI
Foot radiography and serum markers may be effective screening tools for early prevention and therapy.
The VITAL randomized clinical trial tested vitamin D and marine omega-3 fatty acid supplements in the primary prevention of cancer and cardiovascular disease.
Active vitamin D does not appear to improve bone strength or reduce fracture risk beyond PTH suppression in patients on dialysis.
On January 1, 2021, calcimimetics such as etelcalcetide were no longer reimbursed using the Transitional Drug Add-On Payment Adjustment.
Paricalcitol Independently Increases Hemoglobin Levels
Investigators used observational data to study the comparative effectiveness of SHPT treatments in patients on hemodialysis.
Investigators examined the trajectory of nutrition parameters in patients on hemodialysis by degree of hyperparathyroidism.
Patients with calciphylaxis benefit from multidisciplinary care including nephrology, dermatology, and palliative care, according to a new review.
The 2017 KDIGO guideline for CKD-MBD may be too conservative, according to investigators.
Load More
Open
Next post in Secondary Hyperparathyroidism
Close
Close more info about Vitamin D Supplementation Less Effective With Higher BMI
Loading...
Close more info about Vitamin D Supplementation Less Effective With Higher BMI
Loading...